Outset Medical, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 9, 2026 (14 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Feb 12, 2026 | BTIG | maintain | Buy → Buy | $15 | 52% |
| Jan 7, 2026 | Stifel | maintain | Buy → Buy | $8 | 53% |
| Dec 16, 2025 | BTIG | reiterate | Buy → Buy | $17 | 52% |
| Nov 11, 2025 | Stifel | maintain | Buy → Buy | $14 | 53% |
| Nov 11, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $17 | 55% |
| Nov 11, 2025 | BTIG | maintain | Buy → Buy | $17 | 52% |
| Aug 19, 2025 | RBC Capital | reiterate | Sector Perform → Sector Perform | $22 | 55% |
| Aug 7, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $22 | 55% |
| May 21, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $21 | 55% |
| May 8, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $14 | 55% |
| Jan 7, 2025 | RBC Capital | reiterate | Sector Perform → Sector Perform | $3 | 55% |
| Aug 8, 2024 | RBC Capital | downgrade | Outperform → Sector Perform | $3 | 55% |
| Aug 8, 2024 | TD Cowen | maintain | Buy → Buy | $3 | 54% |
| Jun 21, 2024 | RBC Capital | upgrade | Sector Perform → Outperform | $6 | 55% |
| Apr 8, 2024 | BTIG | initiate | — → Buy | $6 | 52% |
| Jan 12, 2024 | RBC Capital | downgrade | Outperform → Sector Perform | $6 | 55% |
| Dec 4, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $5.5 | 54% |
| Nov 14, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $5 | 54% |
| Oct 13, 2023 | RBC Capital | maintain | Outperform → Outperform | $17 | 55% |
| Oct 13, 2023 | Stifel | maintain | Buy → Buy | $6 | 53% |
| Oct 13, 2023 | B of A Securities | downgrade | Buy → Underperform | $3 | 53% |
| Aug 24, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $19 | 54% |
| Aug 17, 2023 | RBC Capital | reiterate | Outperform → Outperform | $29 | 55% |
| Aug 17, 2023 | CL King | initiate | — → Neutral | $0 | 50% |
| Aug 3, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $22 | 54% |
| May 31, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $23 | 54% |
| May 15, 2023 | RBC Capital | reiterate | Outperform → Outperform | $29 | 55% |
| May 4, 2023 | RBC Capital | maintain | — → Outperform | $29 | 55% |
| Jan 6, 2023 | Morgan Stanley | maintain | — → Equal-Weight | $27 | 54% |
| Nov 11, 2022 | RBC Capital | initiate | — → Outperform | $23 | 55% |
| Nov 10, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $17 | 54% |
| Nov 9, 2022 | Goldman Sachs | maintain | — → Buy | $29 | 54% |
| Oct 11, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $19 | 54% |
| Aug 3, 2022 | Goldman Sachs | maintain | — → Buy | $34 | 54% |
| Aug 2, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $22 | 54% |
| Jul 18, 2022 | Stifel | maintain | — → Buy | $24 | 53% |
| Jul 14, 2022 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $20 | 54% |
| Jun 14, 2022 | Cowen & Co. | maintain | — → Outperform | $33 | — |
| Jun 14, 2022 | Stifel | maintain | — → Buy | $30 | 53% |
| May 5, 2022 | Morgan Stanley | maintain | — → Overweight | $48 | 54% |
| May 5, 2022 | SVB Leerink | maintain | — → Outperform | $55 | — |
| Aug 18, 2021 | Cowen & Co. | initiate | — → Outperform | $70 | — |
| Aug 9, 2021 | Morgan Stanley | maintain | — → Equal-Weight | $55 | 54% |
| May 6, 2021 | Morgan Stanley | maintain | — → Equal-Weight | $60 | 54% |
| Apr 19, 2021 | Wells Fargo | initiate | — → Overweight | $63 | 54% |
| Mar 10, 2021 | Morgan Stanley | maintain | — → Equal-Weight | $58 | 54% |
| Dec 16, 2020 | Oppenheimer | initiate | — → Perform | $0 | 52% |
| Dec 15, 2020 | Morgan Stanley | maintain | — → Equal-Weight | $52 | 54% |
| Oct 12, 2020 | Morgan Stanley | initiate | — → Equal-Weight | $48 | 54% |
| Oct 12, 2020 | Stifel | initiate | — → Buy | $54 | 53% |
No cross-platform signals in the last 90 days